MSTR three-lens brief
Evidence-based stock research on MSTR. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -3.65% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved -3.65% yesterday.
- Outperforming SPY by 29.1pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $380.43 — 114% above current (14 analysts).
- Negative free cash flow last quarterly (-$3.36B).
MSTR closed at $177.69 (-3.65%) as of 2026-05-13. Market cap: $62.31B. Positives: outperforming SPY by 29.1pp over 30 days.; analyst mean target $380.43 — 114% above current (14 analysts).. Concerns: moved -3.65% yesterday.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $122.99M, net income -$12.62B, free cash flow -$3.36B.
Why three lenses on MSTR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MSTRacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MSTR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MSTR brief"></iframe>